Abstract:Increasing evidence has shown that stromal interaction molecule 1 (STIM1), a key subunit of store-operated Ca2+ entry (SOCE), is closely associated with tumor growth, development, and metastasis. However, there is no report of a comprehensive assessment of STIM1 in pan-cancer. This study aimed to perform a general analysis of STIM1 in human tumors, including its molecular characteristics, functional mechanisms, clinical significance, and immune infiltrates correlation based on pan-cancer data from The Cancer Genome Atlas (TCGA). Gene expression analysis was investigated using TCGA RNA-seq data, the Tumor Immune Estimation Resource (TIMER). Phosphorylation analysis was undertaken using the Clinical Proteomic Tumor Analysis Consortium (CP-TAC) and the PhosphoNET database. Genetic alterations of STIM1 were analyzed using cBioPortal. Prognostic analysis was via the R package "survival" function and the Kaplan-Meier plotter. Functional enrichment analysis was via by the R package "cluster Profiler" function. The association between STIM1 and tumor-infiltrating immune cells and immune markers was by the R package "GSVA" function and TIMER. STIM1 was differentially expressed and associated with distinct clinical stages in multiple tumors. The phosphorylation of STIM1 at S673 is highly expressed in clear cell renal carcinoma and lung adenocarcinoma tumors compared to normal tissues. STIM1 genetic alterations correlate with poor prognosis in several tumors, including ovarian cancer and lung squamous cell carcinomas. High STIM1 expression is associated with good or poor prognosis across diverse tumors. Overall survival (OS) analysis indicated that STIM1 is a favorable prognostic factor for patients with BRCA, KIRC, LIHC, LUAD, OV, SARC, and UCEC, and is a risk prognostic factor for BLCA, KIRP, STAD, and UVM. There is a close correlation between STIM1 expression and immune cell infiltration, immune-regulated genes, chemokines, and immune checkpoints in a variety of tumors. STIM1 functions differently in diverse tumors, playing an oncogenic or antitumor role. Moreover, It may serve as a prognostic biomarker and an immunotherapy target across multiple tumors.

Knockdown of STIM1 Expression Inhibits Non-Small-cell Lung Cancer Cell Proliferation in Vitro and in Nude Mouse Xenografts.

Suppression of Stromal Interaction Molecule 1 Inhibits SMMC7721 Hepatocellular Carcinoma Cell Proliferation by Inducing Cell Cycle Arrest.

Blocking of Stromal Interaction Molecule 1 Expression Influence Cell Proliferation and Promote Cell Apoptosis in Vitro and Inhibit Tumor Growth in Vivo in Head and Neck Squamous Cell Carcinoma

STIP overexpression confers oncogenic potential to human non‐small cell lung cancer cells by regulating cell cycle and apoptosis

Stromal Interaction Molecule 1 (STIM1) is a Potential Prognostic Biomarker and Correlates with Immune Infiltrates in Solid Tumors.

PDLIM5 Inhibits STUB1-mediated Degradation of SMAD3 and Promotes the Migration and Invasion of Lung Cancer Cells.

Stromal Interaction Molecule 1 (STIM1) Knock Down Attenuates Invasion and Proliferation and Enhances the Expression of Thyroid-Specific Proteins in Human Follicular Thyroid Cancer Cells.

Suppression of STIM1 Inhibits the Migration and Invasion of Human Prostate Cancer Cells and is Associated with PI3K/Akt Signaling Inactivation

Stromal Interaction Molecule 1 Promotes Tumor Growth in Esophageal Squamous Cell Carcinoma.

The Apoptosis of Non-Small Cell Lung Cancer Induced by Cisplatin Through Modulation of STIM1

STIM1, a Direct Target of Microrna-185, Promotes Tumor Metastasis and is Associated with Poor Prognosis in Colorectal Cancer.

STIM1 plays an important role in TGF-β-induced suppression of breast cancer cell proliferation.

STK31 Regulates the Proliferation and Cell Cycle of Lung Cancer Cells Via the Wnt/β‑catenin Pathway and Feedback Regulation by C‑myc.

Mst1 Overexpression Inhibited the Growth of Human Non-Small Cell Lung Cancer in Vitro and in Vivo.

Stathmin1 Increases Radioresistance by Enhancing Autophagy in Non-Small-cell Lung Cancer Cells.

STIM1 Promotes Cervical Cancer Progression Through Autophagy Activation Via TFEB Nuclear Translocation

T-cell Immunoglobulin and Mucin Domain 1 Expression in Human Non-Small-cell Lung Cancer Tissues and Its Clinical Significance

SOSTDC1 is Down-Regulated in Non-Small Cell Lung Cancer and Contributes to Cancer Cell Proliferation

Inhibition of Stromal-Interacting Molecule 1-Mediated Store-Operated Ca2+ Entry As a Novel Strategy for the Treatment of Acquired Imatinib-Resistant Gastrointestinal Stromal Tumors

The expression of stathmin and its clinical significance in NSCLC

STIM1 Accelerates Cell Senescence in a Remodeled Microenvironment but Enhances the Epithelial-to-mesenchymal Transition in Prostate Cancer